(0.81%) 5 058.80 points
(0.75%) 38 187 points
(1.35%) 15 817 points
(-0.11%) $78.91
(5.59%) $2.04
(0.22%) $2 316.10
(0.61%) $26.91
(1.08%) $965.25
(-0.05%) $0.933
(-0.31%) $11.00
(-0.04%) $0.798
(-1.35%) $92.01
4 days till quarter result
(bmo 2024-05-06)
Expected move: +/- 8.01%
@ $24.09
जारी किया गया: 15 Feb 2024 @ 02:13
वापसी: -8.51%
पिछला सिग्नल: Feb 14 - 02:16
पिछला सिग्नल:
वापसी: 0.75 %
Live Chart Being Loaded With Signals
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease...
Stats | |
---|---|
आज की मात्रा | 655 498 |
औसत मात्रा | 767 552 |
बाजार मूल्य | 952.68M |
EPS | $0 ( 2024-04-29 ) |
अगली कमाई की तारीख | ( $-0.510 ) 2024-05-06 |
Last Dividend | $5.25 ( 2012-12-13 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.50 |
ATR14 | $0.0160 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-26 | Robertson Sanford | Buy | 69 000 | Common Stock |
2024-01-03 | Robertson Sanford | Buy | 354 740 | Common Stock Warrant |
2024-04-26 | Robertson Sanford | Sell | 46 000 | Common Stock Warrant |
2024-01-03 | Robertson Sanford | Buy | 72 000 | Common Stock Warrant |
2024-04-23 | Barry Richard | Buy | 176 085 | Common Stock |
INSIDER POWER |
---|
71.89 |
Last 91 transactions |
Buy: 2 502 072 | Sell: 652 285 |
मात्रा सहसंबंध
Cassava Sciences Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
CBIO | 0.848 |
GOOD | 0.844 |
ALXO | 0.828 |
ANGN | 0.828 |
CTBI | 0.825 |
MIRO | 0.819 |
RPRX | 0.813 |
CMPX | 0.813 |
DCRC | 0.808 |
BLUE | 0.806 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
RNA | -0.87 |
VKTX | -0.844 |
BWMX | -0.833 |
MTRY | -0.832 |
DKDCA | -0.826 |
CFFE | -0.823 |
ROCL | -0.821 |
LRMR | -0.821 |
AMPH | -0.814 |
EDTX | -0.811 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Cassava Sciences Inc सहसंबंध - मुद्रा/वस्त्र
Cassava Sciences Inc वित्तीय
Annual | 2023 |
राजस्व: | $0 |
सकल लाभ: | $-1.53M (0.00 %) |
EPS: | $-2.32 |
FY | 2023 |
राजस्व: | $0 |
सकल लाभ: | $-1.53M (0.00 %) |
EPS: | $-2.32 |
FY | 2022 |
राजस्व: | $-1 800.00 |
सकल लाभ: | $-1.30M (72 377.78 %) |
EPS: | $-1.800 |
FY | 2021 |
राजस्व: | $0.00 |
सकल लाभ: | $0.00 (0.00 %) |
EPS: | $-0.820 |
Financial Reports:
No articles found.
Cassava Sciences Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $14.00 | 2010-12-13 |
Last Dividend | $5.25 | 2012-12-13 |
Next Dividend | $0 | N/A |
Payout Date | 2012-12-24 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $19.25 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.22 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $14.00 | 37.20% |
2011 | $0 | 0.00% |
2012 | $5.25 | 19.20% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -40.28 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.624 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.560 | 1.500 | -7.33 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.13 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.60 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 8.53 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.944 | 2.00 | -0.648 | -1.296 | [0 - 30] |
freeCashFlowPerShareTTM | -1.954 | 2.00 | -0.977 | -1.954 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.348 | 1.000 | 7.53 | 7.53 | [0.2 - 0.8] |
operatingProfitMarginTTM | -45.29 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.0155 | 0.800 | -3.23 | -2.58 | [0.5 - 2] |
Total Score | -1.853 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -9.88 | 1.000 | -1.099 | 0 | [1 - 100] |
returnOnEquityTTM | -0.560 | 2.50 | -4.71 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.954 | 2.00 | -0.651 | -1.954 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.944 | 2.00 | -0.648 | -1.296 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0432 | 1.500 | -3.62 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -34.93 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.91 |
Cassava Sciences Inc
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं